Bullish
Protagonist Therapeutics Jumps 6.1% Amid Sector-Wide Rally
Protagonist Therapeutics (PTGX) saw its stock surge by 6.1% to $101.19, driven by a sector-wide rally in biotechnology stocks. The company's gains wer...
PTGX
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (2)
Bearish (0)
Latest PTGX News
Neutral
Legal & General Group Plc Has $13.03 Million Stake in Protagonist Therapeutics, Inc. $PTGX
Legal & General Group Plc reduced its stake in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 4.3% during the 4th quarter, Ho...
Neutral
Wolfe Research initiates Protagonist Therapeutics stock with outperform rating By Investing.com
Wolfe Research has initiated coverage on Protagonist Therapeutics (NASDAQ: PTGX) with an outperform rating and a price target of $135, citing the comp...
Research PTGX on:
Ad Space